Deutsche Bank
SRPT icon

Deutsche Bank’s Sarepta Therapeutics SRPT Stock Holding History

Deutsche Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,650
Closed -$91K – 5589
2017
Q4 		$91K Hold
1,650
– – ﹤0.01% 4279
2017
Q3 		$74K Hold
1,650
– – ﹤0.01% 4263
2017
Q2 		$55K Hold
1,650
– – ﹤0.01% 4355
2017
Q1 		$48K Buy
+1,650
New +$51.1K ﹤0.01% 4239

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's SRPT Position: Q1 2026 in Review

Deutsche Bank increased its Sarepta Therapeutics (SRPT) stake by 5.9% in Q1 2026, buying an estimated $13.7K and bringing the position to 12,700 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Deutsche Bank first reported a position in SRPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $249M in Q2 2024. 340 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Deutsche Bank held 12,700 shares of Sarepta Therapeutics worth $276K as of Q1 2026.
  • Deutsche Bank bought 710 Sarepta Therapeutics shares in Q1 2026, an estimated $13.7K.
  • Sarepta Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2862 holding.
  • Deutsche Bank first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Sarepta Therapeutics position peaked at $249M in Q2 2024.
  • 340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.